MYX 0.00% $4.60 mayne pharma group limited

New Product Approvals, page-65

  1. 13,333 Posts.
    lightbulb Created with Sketch. 93
    MYX going through a huge accumulation here.
    Growing rev in specialised segment will surpass generic segment in 2020-2021.
    Hence, MYX will be the great mid cap bio stock for 2020-21.

    It could also be taken over by another company or it will keep moving towards the gaps at 55c & 67c.
    Due to 2019 weak FA, MYX became one of the shorted stocks. But as history repeats & experienced from $FMG, $TLS, $QAN and recently from $SYR, $ORE, $GXY, $PLS, $SDA that once FA start improving and big players release the break; the stock can gain 20-40% in matter of few weeks
    I did well with $SDA, $ORE, $GXY, $PLS, $TLS and $FMG.
    I am sure research and patience will also play out will with $MYX.

    Nicely accumulated at the bottom tight range. Just need bit more patience to let it unfold.
    https://hotcopper.com.au/data/attachments/1927/1927233-3e31994077aa45339703c030cec6dcb5.jpg
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.60
Change
0.000(0.00%)
Mkt cap ! $387.9M
Open High Low Value Volume
$4.57 $4.61 $4.48 $292.6K 64.34K

Buyers (Bids)

No. Vol. Price($)
6 632 $4.60
 

Sellers (Offers)

Price($) Vol. No.
$4.61 882 9
View Market Depth
Last trade - 11.57am 20/06/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.